| Mark K Santillan, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 356-1616 | |
| (319) 384-6004 |
| Full Name | Mark K Santillan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114137668 | NPI | - | NPPES |
| 70396 | Other | IA | WELLMARK BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 36593 (Iowa) | Primary |
| 207V00000X | Obstetrics & Gynecology | 36593 (Iowa) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
Men with naturally high levels of the female hormone oestrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK published today in the Journal of Clinical Oncology.
On Monday, USAID Administrator Rajiv Shah "announced the launch of the agency's first-ever policy and program guidance on Building Resilience to Recurrent Crisis during an event in Washington, D.C.," according to an USAID press release.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced positive final results from its phase 2a clinical trial of NurOwn™ in amyotrophic lateral sclerosis (ALS) patients, which enrolled 14 subjects at Hadassah Medical Center in Jerusalem.
With a 600 million plus population and pharmaceutical market demand of USD21.3 billion in 2014, Association of Southeast Asian Nations (ASEAN) is poised to be the next economic powerhouse of Asia, through efforts such as the ASEAN Harmonization and Bioeconomy Transformation Programme.
› Verified 4 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Men with naturally high levels of the female hormone oestrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK published today in the Journal of Clinical Oncology.
On Monday, USAID Administrator Rajiv Shah "announced the launch of the agency's first-ever policy and program guidance on Building Resilience to Recurrent Crisis during an event in Washington, D.C.," according to an USAID press release.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced positive final results from its phase 2a clinical trial of NurOwn™ in amyotrophic lateral sclerosis (ALS) patients, which enrolled 14 subjects at Hadassah Medical Center in Jerusalem.
With a 600 million plus population and pharmaceutical market demand of USD21.3 billion in 2014, Association of Southeast Asian Nations (ASEAN) is poised to be the next economic powerhouse of Asia, through efforts such as the ASEAN Harmonization and Bioeconomy Transformation Programme.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark K Santillan, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-1616 | Mark K Santillan, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-1616 |
News Archive
Men with naturally high levels of the female hormone oestrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK published today in the Journal of Clinical Oncology.
On Monday, USAID Administrator Rajiv Shah "announced the launch of the agency's first-ever policy and program guidance on Building Resilience to Recurrent Crisis during an event in Washington, D.C.," according to an USAID press release.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced positive final results from its phase 2a clinical trial of NurOwn™ in amyotrophic lateral sclerosis (ALS) patients, which enrolled 14 subjects at Hadassah Medical Center in Jerusalem.
With a 600 million plus population and pharmaceutical market demand of USD21.3 billion in 2014, Association of Southeast Asian Nations (ASEAN) is poised to be the next economic powerhouse of Asia, through efforts such as the ASEAN Harmonization and Bioeconomy Transformation Programme.
› Verified 4 days ago
Sofia Gabrilovich, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 813-416-4223 | |
Ashley Kaiser, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Obgyn, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-356-7533 | |
Barrie Anderson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, University Of Iowa Hospitals & Clinics, Iowa City, IA 52242 Phone: 319-356-2015 Fax: 319-353-8363 | |
Dr. Margaret Long Foster, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr Dept Obgyn, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-384-8620 | |
Dr. Garrett K. Lam, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1616 Fax: 319-356-2133 | |
Dr. Megan Elaine Mcdonald, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2015 Fax: 319-353-8363 | |
Dr. Christopher D Clark, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2294 Fax: 319-384-9693 |